Cite
HARVARD Citation
Priskorn, L. et al. (2021). Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapy. Human reproduction. 36 (9), pp. 2443-2451. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Priskorn, L. et al. (2021). Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapy. Human reproduction. 36 (9), pp. 2443-2451. [Online].